FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W114852567> ?p ?o ?g. }

• W114852567 endingPage "2427" @default.
• W114852567 startingPage "2417" @default.
• W114852567 abstract "A prospective, multinational randomized controlled trial (RCT) and a complementary single-arm study evaluated the 2-year safety and effectiveness of a paclitaxel-coated drug-eluting stent (DES) in patients with superficial femoral artery lesions. The RCT compared the DES with percutaneous transluminal angioplasty (PTA) and provisional bare-metal stent (BMS) placement.Local drug delivery for superficial femoral artery lesions has been investigated with the intent of limiting restenosis similarly to DES for the coronary arteries. One-year outcomes of DES in the superficial femoral artery are promising, but longer-term benefits have not been established.In the RCT, patients were randomly assigned to primary DES implantation (n = 236) or PTA (n = 238). Acute PTA failure occurred in 120 patients, who underwent secondary randomization to DES (n = 61) or BMS (n = 59) placement. The single-arm study enrolled 787 patients with DES treatment.Compared with the control group, the primary DES group demonstrated significantly superior 2-year event-free survival (86.6% vs. 77.9%, p = 0.02) and primary patency (74.8% vs. 26.5%, p < 0.01). In addition, the provisional DES group exhibited superior 2-year primary patency compared with the provisional BMS group (83.4% vs. 64.1%, p < 0.01) and achieved higher sustained clinical benefit (83.9% vs. 68.4%, p = 0.05). Two-year freedom from target lesion revascularization with primary DES placement was 80.5% in the single-arm study and 86.6% in the RCT.Two-year outcomes with the paclitaxel-eluting stent support its sustained safety and effectiveness in patients with femoropopliteal artery disease, including the long-term superiority of the DES to PTA and to provisional BMS placement. (Evaluation of the Zilver PTX Drug-Eluting Stent in the Above-the-Knee Femoropopliteal Artery; NCT00120406; Zilver(®) PTX™ Global Registry; NCT01094678)." @default.
• W114852567 created "2016-06-24" @default.
• W114852567 creator A5003726398 @default.
• W114852567 creator A5006083917 @default.
• W114852567 creator A5011108372 @default.
• W114852567 creator A5023019539 @default.
• W114852567 creator A5029900766 @default.
• W114852567 creator A5037533038 @default.
• W114852567 creator A5038379911 @default.
• W114852567 creator A5065985671 @default.
• W114852567 creator A5069076517 @default.
• W114852567 creator A5075548351 @default.
• W114852567 creator A5083044150 @default.
• W114852567 creator A5085165353 @default.
• W114852567 date "2013-06-01" @default.
• W114852567 modified "2023-10-01" @default.
• W114852567 title "Sustained Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Lesions" @default.
• W114852567 cites W1969838166 @default.
• W114852567 cites W1998483781 @default.
• W114852567 cites W2008850799 @default.
• W114852567 cites W2029653225 @default.
• W114852567 cites W2040160562 @default.
• W114852567 cites W2051337042 @default.
• W114852567 cites W2062321446 @default.
• W114852567 cites W2075517826 @default.
• W114852567 cites W2076960534 @default.
• W114852567 cites W2085883414 @default.
• W114852567 cites W2102187172 @default.
• W114852567 cites W2132880199 @default.
• W114852567 cites W2136537594 @default.
• W114852567 cites W2147137884 @default.
• W114852567 cites W2168393911 @default.
• W114852567 cites W2325365129 @default.
• W114852567 cites W2569906950 @default.
• W114852567 cites W2615477391 @default.
• W114852567 cites W2887208783 @default.
• W114852567 doi "https://doi.org/10.1016/j.jacc.2013.03.034" @default.
• W114852567 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23583245" @default.
• W114852567 hasPublicationYear "2013" @default.
• W114852567 type Work @default.
• W114852567 sameAs 114852567 @default.
• W114852567 citedByCount "295" @default.
• W114852567 countsByYear W1148525672013 @default.
• W114852567 countsByYear W1148525672014 @default.
• W114852567 countsByYear W1148525672015 @default.
• W114852567 countsByYear W1148525672016 @default.
• W114852567 countsByYear W1148525672017 @default.
• W114852567 countsByYear W1148525672018 @default.
• W114852567 countsByYear W1148525672019 @default.
• W114852567 countsByYear W1148525672020 @default.
• W114852567 countsByYear W1148525672021 @default.
• W114852567 countsByYear W1148525672022 @default.
• W114852567 countsByYear W1148525672023 @default.
• W114852567 crossrefType "journal-article" @default.
• W114852567 hasAuthorship W114852567A5003726398 @default.
• W114852567 hasAuthorship W114852567A5006083917 @default.
• W114852567 hasAuthorship W114852567A5011108372 @default.
• W114852567 hasAuthorship W114852567A5023019539 @default.
• W114852567 hasAuthorship W114852567A5029900766 @default.
• W114852567 hasAuthorship W114852567A5037533038 @default.
• W114852567 hasAuthorship W114852567A5038379911 @default.
• W114852567 hasAuthorship W114852567A5065985671 @default.
• W114852567 hasAuthorship W114852567A5069076517 @default.
• W114852567 hasAuthorship W114852567A5075548351 @default.
• W114852567 hasAuthorship W114852567A5083044150 @default.
• W114852567 hasAuthorship W114852567A5085165353 @default.
• W114852567 hasBestOaLocation W1148525671 @default.
• W114852567 hasConcept C126322002 @default.
• W114852567 hasConcept C126838900 @default.
• W114852567 hasConcept C141071460 @default.
• W114852567 hasConcept C168563851 @default.
• W114852567 hasConcept C204243189 @default.
• W114852567 hasConcept C2778283817 @default.
• W114852567 hasConcept C2778583881 @default.
• W114852567 hasConcept C2779723990 @default.
• W114852567 hasConcept C2780326628 @default.
• W114852567 hasConcept C2780400711 @default.
• W114852567 hasConcept C2781464078 @default.
• W114852567 hasConcept C500558357 @default.
• W114852567 hasConcept C71924100 @default.
• W114852567 hasConceptScore W114852567C126322002 @default.
• W114852567 hasConceptScore W114852567C126838900 @default.
• W114852567 hasConceptScore W114852567C141071460 @default.
• W114852567 hasConceptScore W114852567C168563851 @default.
• W114852567 hasConceptScore W114852567C204243189 @default.
• W114852567 hasConceptScore W114852567C2778283817 @default.
• W114852567 hasConceptScore W114852567C2778583881 @default.
• W114852567 hasConceptScore W114852567C2779723990 @default.
• W114852567 hasConceptScore W114852567C2780326628 @default.
• W114852567 hasConceptScore W114852567C2780400711 @default.
• W114852567 hasConceptScore W114852567C2781464078 @default.
• W114852567 hasConceptScore W114852567C500558357 @default.
• W114852567 hasConceptScore W114852567C71924100 @default.
• W114852567 hasFunder F4320312085 @default.
• W114852567 hasFunder F4320323077 @default.
• W114852567 hasFunder F4320333259 @default.
• W114852567 hasIssue "24" @default.
• W114852567 hasLocation W1148525671 @default.

• next